Brief: Nymox Appeals Deficiency Letter
06/01/2023 21:37
Jan 6 (Reuters) - Nymox Pharmaceutical Corp NYMX.O :
* NYMOX APPEALS DEFICIENCY LETTER
* NYMOX PHARMACEUTICAL - TODAY APPEALED DECISION AND
REQUESTED A
HEARING BEFORE NASDAQ, ON BASIS THAT IT BELIEVES IT HAS A PLAN
TO REGAIN COMPLIANCE
* NYMOX PHARMACEUTICAL CORP - PENDING APPEAL PROCEDURE,
THERE IS A
STAY OF DELISTING
Source text for Eikon: ID:nGNX195M9Q
Further company coverage: NYMX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Nymox Pharmaceutical
See all newsBrief: Nymox Says Required To Resubmit Application To DKMA
Brief: Nymox Pharmaceutical Corp Says Terminated Employment Of Christopher R Riley As CFO (June 27)
Brief: Nymox Announces Appointment Of Christopher R. Riley As Chief Financial Officer
Brief: Nymox Appeals Deficiency Letter
U.S. STOCKS ON THE MOVE-Pot stocks, Nymox, Zynerba